Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy By Reuters
© Reuters. Photograph: Lee Jae-won/Reuters.
Written by Raghav Mahobey (Reuters) - Pharmaceutical company Ironwood said on Monday it will buy Swiss-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising…
